Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s457303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Eleftherios Chatzimichail und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Diabetic Retinopathy, Macular Edema, Wet Macular Degeneration. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland.
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
- Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK.
- Division of Ophthalmology and Visual Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Eleftherios Chatzimichail, Georgios D Panos
Zitieren
APA
Chatzimichail, E., Pfau, K., Gatzioufas, Z., & Panos, G. D. (2024). Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s457303
Vancouver
Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD. Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s457303
BibTeX
@article{Chatzimichail2024,
author = {Chatzimichail, Eleftherios and Pfau, Kristina and Gatzioufas, Zisis and Panos, Georgios D},
title = {Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s457303}
}
EUVIMED